Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5006 |  SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.23 USD | -8.00% | -20.69% | -43.90% | -85.71% | 1.28 M USD | ||
| 5011 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 1.99 USD | -5.69% | -11.16% | -27.11% | +192.65% | 1.15 M USD | ||
| 5046 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 1.21 USD | +7.08% | -6.92% | -27.98% | +59.21% | 419.65 K USD | ||
| 5092 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 0.52 USD | -7.14% | -16.13% | -35.00% | -62.86% | 46.97 K USD | ||
| 5095 |  CDT CDT Equity Inc. - Common Stock | 0.80 USD | -4.76% | -37.50% | +95.12% | +48.15% | 25.17 K USD | ||
| 5100 |  CMND Clearmind Medicine Inc. - Common Shares | 6.60 USD | 0.00% | +816.67% | +560.00% | +573.47% | 13.04 K USD | ||
| 5134 |  GMAB Genmab A/S - American Depositary Shares | 36.05 USD | -1.64% | +4.83% | +11.06% | +13.01% | 0 USD | ||
| 5166 |  OCS Oculis Holding AG - Ordinary shares | 8.66 USD | +1.88% | -1.81% | -23.70% | -59.72% | 0 USD | ||
| 5179 |  ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 USD | +10.39% | -1.59% | +3.61% | +817.75% | 0 USD | ||
| 5250 |  NVO Novo Nordisk A/S | 38.16 USD | -0.26% | +1.38% | -14.44% | -34.90% | 0 USD | ||
| 5466 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1149 USD | -11.62% | -11.62% | 0.00% | +198.44% | 0 USD | ||
| 6285 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -76.19% | 0 USD | ||
| 6408 |  RVMDW Revolution Medicines, Inc. - Warrant | 9.4400 USD | -12.27% | -19.45% | -17.19% | +3142.87% | 40.32 B USD | ||
| 6637 |  NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.04% | -39.33% | 2.54 B USD | ||
| 6709 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.5600 USD | -1.11% | -12.10% | -11.66% | +917.14% | 1.23 B USD | ||
| 6823 |  YDESW YD Bio Limited - Warrants | 0.5000 USD | -23.08% | -28.57% | +33.33% | -76.30% | 409.87 M USD | ||
| 6953 |  SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 USD | -27.87% | -40.94% | -42.48% | -68.79% | 262.95 M USD | ||
| 7057 |  ENGNW enGene Therapeutics Inc. - Warrants | 0.1700 USD | 0.00% | -32.00% | -5.66% | -79.01% | 119.29 M USD | ||
| 7102 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 17.78 USD | -1.33% | +9.75% | -4.10% | +149.72% | 76.87 M USD | ||
| 7105 |  NTRBW Nutriband Inc. - Warrant | 0.5500 USD | 0.00% | -32.10% | +83.33% | -67.65% | 75.37 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |